Kite Pharma

Businessman about to be crushed by falling dominos

Fierce Pharma

BioNTech to wind down cell therapy manufacturing in Maryland

After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.

Fraiser Kansteiner Jun 18, 2025 10:23am

rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm

Gilead

Gilead to lay off 72 staffers, shutter Seattle R&D office

Nov 14, 2024 1:09pm

Rendering of an immune cell

ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma

Nov 5, 2024 3:08pm

Professional kite surfer soars through the air

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders

Sep 20, 2024 8:30am

Alps parachute rainbow mountains

J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders

Jun 14, 2024 8:30am